Table 1.
Demographic and PCa-related characteristics of the patients
| Parameters | General population (n=210) | NLR<2.5 (n=104) | NLR ≥2.5 (n=106) | p value |
|---|---|---|---|---|
| Age, mean ± SD | 59.2 ± 8.1 | 59.7 ± 8.8 | 58.6 ± 7.9 | 0.855 |
| PSA, mean ± SD | 5.4 ± 1.1 | 5.28 ± 1.0 | 5.5 ± 1.1 | 0.122 |
| No. of positive cores | 0.179 | |||
| One core positive, n (%) | 98 (46.7) | 47 (45.2) | 51 (48.1) | |
| Two cores positive, n (%) | 112 (53.3) | 57 (54.8) | 55 (51.9) | |
| Maximum percentage of cancer in a core, mean ± SD | 22.1 ± 9.9 | 22.02 ± 9.6 | 22.17 ± 10.6 | 0.749 |
| Clinical stage | 0.568 | |||
| cT1c, n (%) | 197 (93.8) | 99 (95.2) | 98 (92.5) | |
| cT2a, n (%) | 13 (6.2) | 5 (4.8) | 8 (7.5) |
PCa: prostate cancer; PSA: prostate-specific antigen; NLR: neutrophil-to-lymphocyte ratio; SD: standard deviation.